Valeo Pharmainc (VPH.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.660 unch (unch) 03/28/22 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.660 unch (unch) -
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2023 | 10-2022 | 10-2021 | 10-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,626 | 1,418 | 743 | 424 | 135 |
| Income taxes - deferred | 0 | -1,174 | N/A | N/A | N/A |
| Accounts receivable | -1,137 | -3,627 | -583 | -674 | 243 |
| Accounts payable and accrued liabilities | N/A | -4,017 | 6,418 | -775 | 958 |
| Other Working Capital | 4,216 | -11,484 | -1,412 | -2,239 | 645 |
| Other Operating Activity | -21,400 | -9,619 | -17,481 | -2,034 | -4,288 |
| Operating Cash Flow | $-15,695 | $-28,503 | $-12,315 | $-5,298 | $-2,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -478 | -359 | -902 | -62 | -25 |
| Purchase Sale Intangibles | -5,075 | -6,532 | -2,563 | -1,343 | -898 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 22 |
| Investing Cash Flow | $-5,553 | $-6,891 | $-3,465 | $-1,405 | $-923 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,790 | N/A | N/A | N/A | -850 |
| Debt Issued | 0 | 59,807 | 6,830 | 2,838 | 1,900 |
| Debt Repayment | -224 | -1,668 | -4,944 | -875 | -97 |
| Common Stock Issued | 3,920 | 0 | 11,500 | 7,244 | 3,113 |
| Other Financing Activity | -297 | -3,148 | 1,718 | 0 | -513 |
| Financing Cash Flow | $6,189 | $54,991 | $15,104 | $9,207 | $3,553 |
| Exchange Rate Effect | 60 | 861 | -117 | -3 | 1 |
| Beginning Cash Position | 22,501 | 2,043 | 2,836 | 335 | 11 |
| End Cash Position | 7,502 | 22,501 | 2,043 | 2,836 | 335 |
| Net Cash Flow | $-15,059 | $19,597 | $-676 | $2,504 | $323 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,695 | -28,503 | -12,315 | -5,298 | -2,307 |
| Capital Expenditure | -5,553 | -6,891 | -3,465 | -1,405 | -945 |
| Free Cash Flow | -21,248 | -35,394 | -15,780 | -6,703 | -3,252 |